Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients-Reference-Cited by-同舟云学术

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients

Published:2015-07-20 Issue:7 Volume:10 Page:e0132745
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tarhini Ahmad A.,Lin Yan,Zahoor Haris,Shuai Yongli,Butterfield Lisa H.,Ringquist Steven,Gogas Helen,Sander Cindy,Lee Sandra,Agarwala Sanjiv S.,Kirwood John M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. A four-marker signature of TNF-RII, TGF-alpha, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma;AA Tarhini;J Transl Med,2014

2. The immunobiology of cancer immunosurveillance and immunoediting;GP Dunn;Immunity,2004

3. Immune surveillance of tumors;JB Swann;J Clin Invest,2007

4. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma;G Erdag;Cancer Res,2012

5. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma;CG Clemente;Cancer,1996

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models;Cells;2022-03-18

2. Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker;Cancers;2020-12-08

3. Letter in response to Thompson and Scott Authors’ letter reestablished search filters may miss studies when identifying randomized controlled trials. Language for trial phase necessary when searching for RCT;Journal of Clinical Epidemiology;2020-01

4. Role of Treg/Th17 Imbalance, Microbiota and miRNAs in Pancreatic Cancer: Therapeutic Options;Critical Reviews in Immunology;2020

5. Established search filters may miss studies when identifying randomized controlled trials;Journal of Clinical Epidemiology;2019-08